{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:01:19Z","timestamp":1789182079483,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background and Aims:<\/jats:title>\n                    <jats:p>\n                      Self-expandable metallic stents (SEMSs) have been recommended for patients with unresectable malignant biliary obstruction, while radiation-emitting metallic stents (REMSs) loaded with\n                      <jats:sup>125<\/jats:sup>\n                      I seeds have recently been approved to provide longer patency and overall survival in malignant biliary tract obstruction. This trial is to evaluate the efficacy and safety of REMS plus hepatic arterial infusion chemotherapy (REMS-HAIC) versus SEMS plus HAIC (SEMS-HAIC) for unresectable perihilar cholangiocarcinoma (pCCA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This multicenter randomized controlled trial recruited patients with unresectable Bismuth type III or IV pCCA between March 2021 and January 2023. Patients were randomly assigned (1:1 ratio) to receive either REMS-HAIC or SEMS-HAIC using permuted block randomization, with a block size of six. The primary endpoint was overall survival (OS). The secondary endpoints were time to symptomatic progression (TTSP), stent patency, relief of jaundice, quality of life, and safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 126 patients were included in the intent-to-treat population, with 63 in each group. The median OS was 10.2 months versus 6.7 months (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.002). The median TTSP was 8.6 months versus 5.4 months (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.003). The median stent patency was longer in the REMS-HAIC group than in the SEMS-HAIC group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.001). The REMS-HAIC group showed better improvement in physical functioning scale (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05) and fatigue symptoms (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05) when compared to the SEMS-HAIC group. No significant differences were observed in relief of jaundice (85.7% vs. 84.1%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.803) or the incidence of grade 3 or 4 adverse events (9.8% vs. 11.9%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.721).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>REMS plus HAIC showed better OS, TTSP, and stent patency compared with SEMS plus HAIC in patients with unresectable Bismuth type III or IV pCCA with an acceptable safety profile.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000002089","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T12:00:23Z","timestamp":1727092823000},"page":"706-717","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Radiation-emitting metallic stent for unresectable Bismuth type III or IV perihilar cholangiocarcinoma: a multicenter randomized trial"],"prefix":"10.1097","volume":"111","author":[{"given":"Qi","family":"Chen","sequence":"first","affiliation":[{"name":"Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing"},{"name":"Basic Medicine Research and Innovation Center of Ministry of Education, Zhongda Hospital, Southeast University, Nanjing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Jian","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Eastern Hospital of Hepatobiliary Surgery, Navy Medical University (Second Military Medical University), Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Liang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Interventional Medicine, The Second Hospital of Shandong University, Jinan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Interventional Therapy, Yunnan Tumor Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Yancheng Third People\u2019s Hospital, Yancheng"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Lu","sequence":"additional","affiliation":[{"name":"Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei; Department of Radiology, University of Science and Technology of China, Hefei; The First Affiliated Hospital of USTC, Anhui Provincial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Hua","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Subei People\u2019s Hospital of Jiangsu Province (Clinical Medical College of Yangzhou University), Yangzhou, Jiangsu Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Fei","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Lishui Hospital of Zhejiang University, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui Central Hospital, Lishui"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Jian","family":"He","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Eastern Hospital of Hepatobiliary Surgery, Navy Medical University (Second Military Medical University), Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Jie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Interventional Medicine, The Second Hospital of Shandong University, Jinan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Interventional Therapy, Yunnan Tumor Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Interventional Therapy, Yunnan Tumor Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Jun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Yancheng Third People\u2019s Hospital, Yancheng"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-An","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Subei People\u2019s Hospital of Jiangsu Province (Clinical Medical College of Yangzhou University), Yangzhou, Jiangsu Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing"},{"name":"Basic Medicine Research and Innovation Center of Ministry of Education, Zhongda Hospital, Southeast University, Nanjing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[{"name":"Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing"},{"name":"Basic Medicine Research and Innovation Center of Ministry of Education, Zhongda Hospital, Southeast University, Nanjing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[{"name":"Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing"},{"name":"Basic Medicine Research and Innovation Center of Ministry of Education, Zhongda Hospital, Southeast University, Nanjing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Min","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-He","family":"Guo","sequence":"additional","affiliation":[{"name":"Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing"},{"name":"Basic Medicine Research and Innovation Center of Ministry of Education, Zhongda Hospital, Southeast University, Nanjing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-Jun","family":"Teng","sequence":"additional","affiliation":[{"name":"Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing"},{"name":"Basic Medicine Research and Innovation Center of Ministry of Education, Zhongda Hospital, Southeast University, Nanjing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lu","sequence":"additional","affiliation":[{"name":"Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing"},{"name":"Basic Medicine Research and Innovation Center of Ministry of Education, Zhongda Hospital, Southeast University, Nanjing"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1]]},"reference":[{"key":"R1-20260304","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","article-title":"Current epidemiology of cholangiocarcinoma in Western countries","volume":"77","author":"Vithayathil","year":"2022","journal-title":"J Hepatol"},{"key":"R2-20260304","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2023.01.027","article-title":"Advanced endoscopy meets molecular. diagnosis of cholangiocarcinoma","volume":"78","author":"Cadamuro","year":"2023","journal-title":"J Hepatol"},{"key":"R3-20260304","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2022.11.006","article-title":"Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine?","volume":"179","author":"Roth","year":"2023","journal-title":"Eur J Cancer"},{"key":"R4-20260304","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"R5-20260304","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R7-20260304","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/13651820801992567","article-title":"Guidelines for palliative surgery of cholangiocarcinoma","volume":"10","author":"Witzigmann","year":"2008","journal-title":"HPB (Oxford)"},{"key":"R8-20260304","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00261-020-02593-5","article-title":"Advances in stent therapy for malignant biliary obstruction","volume":"46","author":"He","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"R9-20260304","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jhep.2011.12.018","article-title":"A novel biliary stent loaded with (125)I seeds in patients with malignant biliary obstruction: preliminary results versus a conventional biliary stent","volume":"56","author":"Zhu","year":"2012","journal-title":"J Hepatol"},{"key":"R10-20260304","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jhep.2017.12.028","article-title":"Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: a multicenter trial","volume":"68","author":"Zhu","year":"2018","journal-title":"J Hepatol"},{"key":"R11-20260304","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1097\/JS9.0000000000000654","article-title":"Hepatic arterial infusion chemotherapy versus transarterial chemoembolization, potential conversion therapies for single huge hepatocellular carcinoma: a retrospective comparison study","volume":"109","author":"Deng","year":"2023","journal-title":"Int J Surg"},{"key":"R12-20260304","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1245\/s10434-023-14488-y","article-title":"Gemcitabine with cisplatin versus hepatic arterial infusion pump chemotherapy for liver-confined unresectable intrahepatic cholangiocarcinoma","volume":"31","author":"Franssen","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"R13-20260304","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.surg.2023.04.043","article-title":"Adjuvant hepatic artery infusion pump chemotherapy for resected colorectal cancer liver metastases","volume":"174","author":"Standring","year":"2023","journal-title":"Surgery"},{"key":"R14-20260304","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1148\/radiol.2016160572","article-title":"Phase II study of hepatic arterial infusion chemotherapy with oxaliplatin and 5-fluorouracil for advanced perihilar cholangiocarcinoma","volume":"283","author":"Wang","year":"2017","journal-title":"Radiology"},{"key":"R15-20260304","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1745-6215-11-32","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"11","author":"Schulz","year":"2010","journal-title":"Trials"},{"key":"R16-20260304","doi-asserted-by":"crossref","first-page":"e000242","DOI":"10.1136\/esmoopen-2017-000242","article-title":"Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma","volume":"2","author":"Lu","year":"2017","journal-title":"ESMO Open"},{"key":"R18-20260304","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00270-017-1827-6","article-title":"A systematic review and meta-analysis of intraluminal brachytherapy versus stent alone in the treatment of malignant obstructive jaundice","volume":"41","author":"Xu","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R19-20260304","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-0031-1291633","article-title":"Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline","volume":"44","author":"Dumonceau","year":"2012","journal-title":"Endoscopy"},{"key":"R20-20260304","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/jgh.12128","article-title":"Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma","volume":"28","author":"Rerknimitr","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"R21-20260304","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJM200105313442206","article-title":"Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract","volume":"344","author":"Baron","year":"2001","journal-title":"N Engl J Med"},{"key":"R22-20260304","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5946\/ce.2022.218","article-title":"Role of radiofrequency ablation in advanced malignant hilar biliary obstruction","volume":"56","author":"Takenaka","year":"2023","journal-title":"Clin Endosc"},{"key":"R23-20260304","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1097\/MCG.0000000000001524","article-title":"Photodynamic therapy (PDT), radiofrequency ablation (RFA) with biliary stents in palliative treatment of unresectable extrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"56","author":"Mohan","year":"2022","journal-title":"J Clin Gastroenterol"},{"key":"R24-20260304","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.radonc.2021.10.011","article-title":"A systematic review of intraluminal high dose rate brachytherapy in the management of malignant biliary tract obstruction and cholangiocarcinoma","volume":"165","author":"Taggar","year":"2021","journal-title":"Radiother Oncol"},{"key":"R25-20260304","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejrad.2006.10.003","article-title":"Self-expandable stent loaded with 125I seeds: feasibility and safety in a rabbit model","volume":"61","author":"Guo","year":"2007","journal-title":"Eur J Radiol"},{"key":"R26-20260304","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S1470-2045(14)70131-7","article-title":"Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial","volume":"15","author":"Zhu","year":"2014","journal-title":"Lancet Oncol"},{"key":"R27-20260304","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/JS9.0000000000000295","article-title":"Irradiation stent with 125 I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial","volume":"109","author":"Lu","year":"2023","journal-title":"Int J Surg"},{"key":"R28-20260304","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.jvir.2015.06.032","article-title":"Gemcitabine and oxaliplatin, but not sorafenib or paclitaxel, have a synergistic effect with yttrium-90 in reducing hepatocellular carcinoma and cholangiocarcinoma cell line viability","volume":"26","author":"Edeline","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"R29-20260304","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000525489","article-title":"Selective internal radiation therapy with yttrium-90 resin microspheres followed by gemcitabine plus cisplatin for unresectable intrahepatic cholangiocarcinoma: a phase 2 single-arm multicenter clinical trial","volume":"11","author":"Chan","year":"2022","journal-title":"Liver Cancer"},{"key":"R30-20260304","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/jhbp.804","article-title":"The placement of multiple plastic stents still has important roles in candidates for chemotherapy for unresectable perihilar cholangiocarcinoma","volume":"27","author":"Iwasaki","year":"2020","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R31-20260304","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"R32-20260304","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet"},{"key":"R33-20260304","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1148\/radiol.14140293","article-title":"Severe bleeding after percutaneous transhepatic drainage of the biliary system: effect of antithrombotic agents--analysis of 34 606 cases from a Japanese nationwide administrative database","volume":"274","author":"Hamada","year":"2015","journal-title":"Radiology"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:05:25Z","timestamp":1772625925000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000002089","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"2024-02-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}